<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30087660</article-id>
<article-id pub-id-type="pmc">6066498</article-id>
<article-id pub-id-type="doi">10.3389/fmicb.2018.01633</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Interactions Between <italic>Clostridioides difficile</italic> and Fecal Microbiota in <italic>in Vitro</italic> Batch Model: Growth, Sporulation, and Microbiota Changes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Horvat</surname>
<given-names>Sabina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/541408/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rupnik</surname>
<given-names>Maja</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/515200/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Microbiology, Faculty of Medicine, University of Maribor</institution>, <addr-line>Maribor</addr-line>, <country>Slovenia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Centre for Medical Microbiology, National Laboratory for Health, Environment and Food</institution>, <addr-line>Maribor</addr-line>, <country>Slovenia</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Meina Neumann-Schaal, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jozsef Soki, University of Szeged, Hungary; Till Strowig, Helmholtz-Gemeinschaft Deutscher Forschungszentren (HZ), Germany</p>
</fn>
<corresp id="c001">*Correspondence: Maja Rupnik, <email>maja.rupnik@nlzoh.si</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>1633</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Horvat and Rupnik.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Horvat and Rupnik</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Disturbance in gut microbiota is crucial for the development of <italic>Clostridioides difficile</italic> infection (CDI). Different mechanisms through which gut microbiota influences <italic>C. difficile</italic> colonization are known. However, <italic>C. difficile</italic> could also affect gut microbiota balance as previously demonstrated by cultivation of fecal microbiota in <italic>C. difficile</italic> conditioned medium. In current study, the interactions of <italic>C. difficile</italic> cells with gut microbiota were addressed. Three different strains (ribotypes 027, 014/020, and 010) were co-cultivated with two types of fecal microbiota (healthy and dysbiotic) using <italic>in vitro</italic> batch model. While all strains showed higher sporulation frequency in the presence of dysbiotic fecal microbiota, the growth was strain dependent. <italic>C. difficile</italic> either proliferated to comparable levels in the presence of dysbiotic and healthy fecal microbiota or grew better in co-culture with dysbiotic microbiota. In co-cultures with any <italic>C. difficile</italic> strain fecal microbiota showed decreased richness and diversity. Dysbiotic fecal microbiota was more affected after co-culture with <italic>C. difficile</italic> than healthy microbiota. Altogether, 62 OTUs were significantly changed in co-cultures of dysbiotic microbiota/<italic>C. difficile</italic> and 45 OTUs in co-cultures of healthy microbiota/<italic>C. difficile</italic>. However, the majority of significantly changed OTUs in both types of microbiota belonged to the phylum <italic>Firmicutes</italic> with <italic>Lachnospiraceae</italic> and <italic>Ruminococcaceae</italic> origin.</p>
</abstract>
<kwd-group>
<kwd><italic>Clostridioides</italic> (<italic>Clostridium</italic>) <italic>difficile</italic></kwd>
<kwd>gut microbiota</kwd>
<kwd>sporulation</kwd>
<kwd>colonization</kwd>
<kwd>pathogenesis</kwd>
<kwd>CDI</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Javna Agencija za Raziskovalno Dejavnost RS<named-content content-type="fundref-id">10.13039/501100004329</named-content></funding-source>
<award-id rid="cn001">P3-0387</award-id>
<award-id rid="cn001">Young investigator programme (Mladi raziskovalci)</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="48"></ref-count>
<page-count count="10"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p><italic>Clostridium difficile</italic>, recently reclassified as <italic>Clostridioides difficile</italic> (<xref ref-type="bibr" rid="B20">Lawson et al., 2016</xref>), is an ubiquitous, anaerobic, spore-forming, Gram-positive bacterium that is currently the leading cause of nosocomial and community associated diarrhea worldwide (<xref ref-type="bibr" rid="B24">Martin et al., 2016</xref>). <italic>C. difficile</italic> infection (CDI) outcome can range from asymptomatic colonization to diarrhea and more severe, life-threatening pseudomembranous colitis (<xref ref-type="bibr" rid="B35">Rupnik et al., 2009</xref>; <xref ref-type="bibr" rid="B21">Leffler and Lamont, 2015</xref>). CDI is a toxin mediated disease. Two toxins, A and B, are well established as virulence factors, while the presence of the third toxin, binary toxin CDT, is less clear but seems to contribute to disease severity (<xref ref-type="bibr" rid="B13">Gerding et al., 2014</xref>).</p>
<p>Success of enteric pathogen to cause a disease depends mainly on two phases, i.e., the initial colonization phase of pathogen in the gut, followed by pathogen-promoting physiological changes in the gut important for its maintenance (<xref ref-type="bibr" rid="B10">Ferreyra et al., 2014</xref>). The colonization of <italic>C. difficile</italic> is strongly associated with disturbance in gut microbiota (i.e., dysbiosis) and several studies explored the mechanisms through which gut microbiota influences <italic>C. difficile</italic> (<xref ref-type="bibr" rid="B5">Britton and Young, 2012</xref>; <xref ref-type="bibr" rid="B30">Pérez-Cobas et al., 2015</xref>). While for some enteric pathogens (e.g., <italic>Salmonella</italic>) mechanisms involved in the pathogen-promoting physiological changes in the gut have already been described (<xref ref-type="bibr" rid="B39">Stecher et al., 2007</xref>), little is known about possible impact of <italic>C. difficile</italic> on gut microbiota. In our previous work, we have shown that <italic>C. difficile</italic> conditioned medium has specific effect on fecal microbiota and that nutrient competition is the most likely mechanism (<xref ref-type="bibr" rid="B15">Horvat et al., 2017</xref>). Additionally, changed bacterial groups detected in <italic>in vitro</italic> model using <italic>C. difficile</italic> conditioned medium were comparable to those described in CDI patients.</p>
<p>In this study, we have investigated the interactions between <italic>C. difficile</italic> vegetative cells and fecal bacterial communities in a simple <italic>in vitro</italic> model. Several lines of evidence supports the need for dysbiotic gut microbiota for successful <italic>C. difficile</italic> colonization, such as low carriage rates in healthy population, need of antibiotic pretreatment of animals in animal models of CDI and association of dysbiotic gut microbiota with CDI in humans. However, recent increase in community cases without previous antibiotic exposure (<xref ref-type="bibr" rid="B14">Gupta and Khanna, 2014</xref>) suggests that <italic>C. difficile</italic> can colonize gut also in the presence of non-dysbiotic microbiota. In line with this observations are <italic>in vivo</italic> and <italic>in vitro</italic> studies demonstrating capability of <italic>C. difficile</italic> to colonize the gut even in the presence of complex microbiota (<xref ref-type="bibr" rid="B33">Robinson et al., 2014</xref>) and showing that in the absence of some protective species (i.e., <italic>C. scindens</italic>) colonization with <italic>C. difficile</italic> even without antibiotic treatment can result in a significant compositional perturbation of gut microbiota in animal models (<xref ref-type="bibr" rid="B41">Studer et al., 2016</xref>). We have therefore compared two types of fecal samples, one representing healthy microbiota and the other representing dysbiotic microbiota. Healthy microbiota was obtained from healthy donors. As a proxy for dysbiotic microbiota fecal samples sent to routine diagnostic laboratory for testing for <italic>C. difficile</italic> were used. Such samples were shown before to clearly group separately from healthy volunteer samples (<xref ref-type="bibr" rid="B38">Skraban et al., 2013</xref>; <xref ref-type="bibr" rid="B15">Horvat et al., 2017</xref>). The interactions of both fecal microbiota types were tested with three different <italic>C. difficile</italic> strains as representatives of globally widespread PCR ribotypes (027, 014/020, and 010) and three different toxin production types (A+B+CDT+, A+B+CDT-, A-B-CDT-). The strains were selected with the objective to cover large diversity within <italic>C. difficile</italic> species. The aim was not to compare ribotype or toxinotype association with changes in interactions with gut microbiota as only a single representative was used.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>All described cultivation procedures were performed anaerobically at 37°C in an anaerobic workstation (10% CO<sub>2</sub>, 10% H<sub>2</sub>, and 80% N<sub>2</sub>) (Don Whitley Scientific).</p>
<sec>
<title><italic>C. difficile</italic> Strain Selection and Preparation of Vegetative Cells</title>
<p>Three different <italic>C. difficile</italic> strains, belonging to PCR ribotypes 010, 014/020, and 027, were selected from our <italic>C. difficile</italic> strain collection (strain designations ZZV15-6684, ZZV11-3236, ZZV09-2033). Selected strains originated from humans and were isolated between the years 2009 and 2015. Strains were plated onto Columbia agar with 5% horse blood (BioMerieux) and incubated for 48 h. Single colony of each strain was transferred into 5 ml of pre-reduced Wilkins Chalgren Anaerobe Broth (WCAB) (Oxoid) and incubated for 17 h. Overnight cultures of each strain were once again transferred to freshly prepared and pre-reduced WCAB growth medium (1:500, v:v) and incubated for 17 h to obtain suspensions of <italic>C. difficile</italic> vegetative cells with up to 2 × 10<sup>8</sup> colony forming units (CFUs) per ml, respectively.</p>
</sec>
<sec>
<title>Fecal Samples Collection and Preparation of Fecal Inocula</title>
<p><italic>C. difficile</italic> negative fecal samples were randomly selected from (i) non-diarrheal samples sent for <italic>C. difficile</italic> testing (male: <italic>n</italic> = 5, female: <italic>n</italic> = 5, all aged under 65 years) (dysbiotic microbiota) and (ii) samples of healthy individuals (male: <italic>n</italic> = 3, female: <italic>n</italic> = 2, all aged under 65 years) (healthy microbiota). Healthy individuals had not taken antibiotics for at least 3 months prior to donation. Healthy individuals have given informed consent and agreed to use the samples for the experiments. The use for laboratory samples without informed consent was approved by National Medical Ethic Committee.</p>
<p>After donation samples were stored at 4°C for maximally 24 h. Aliquots of 0.2 g of each specimen were prepared and frozen at -80°C until further processing. Based on our previous comparisons of individual and pooled samples and published studies (<xref ref-type="bibr" rid="B1">Aguirre et al., 2014</xref>) we used pooled samples for experiments with fecal microbiota. For pooled slurry preparation each specimen was thawed and diluted in pre-reduced WCAB to obtain 10% fecal slurry. Equal amounts of fecal slurries from each group (i.e., dysbiotic and healthy) were pooled, added to pre-reduced WCAB growth medium (1:100, v:v) and incubated overnight to prepare fecal inocula for <italic>in vitro</italic> cultivation.</p>
</sec>
<sec>
<title><italic>In Vitro</italic> Model Set Up of <italic>C. difficile</italic> and Fecal Microbiota Co-cultivation</title>
<p>Overnight culture of fecal inoculum (50 μl) was combined with suspensions of <italic>C. difficile</italic> vegetative cells (50 μl) in pre-reduced WCAB growth medium (4.9 ml) in a 6-well plate (Sarstedt). Initial concentration of <italic>C. difficile</italic> in co-cultures was approximately 2 × 10<sup>6</sup> CFU/ml. Cultures were gently mixed and incubated for 3 days. Monocultures of fecal microbiota or <italic>C. difficile</italic> grown in freshly prepared and pre-reduced WCAB growth medium were used as controls. Each described growth condition was done in triplicate. Samples (5 ml) were taken after 72 h incubation period and screened for total viable cell count and spore count of <italic>C. difficile</italic> (described below). After centrifugation at 10,000 rpm for 10 min, pellets were used for total bacterial DNA extraction. Additionally, fecal pooled sample before any cultivation (i.e., fecal input sample) was included as a control for 16S rDNA sequencing to test for changes of microbiota due to <italic>in vitro</italic> cultivation.</p>
</sec>
<sec>
<title><italic>C. difficile</italic> Growth and Sporulation</title>
<p>For <italic>C. difficile</italic> total viable cell count serial dilutions were prepared in pre-reduced 0.9% sterile saline and plated onto pre-reduced chromID <italic>C. difficile</italic> agar plates (BioMerieux). <italic>C. difficile</italic> spores were defined as CFUs on chromID <italic>C. difficile</italic> agar plates after treatment with 100% ethanol for 30 min. The frequency of sporulation was determined as the percentage of ethanol resistant cell count relative to total cell count. One-way ANOVA was used in the statistical analysis with Bonferroni correction to determine statistically significantly different samples.</p>
</sec>
<sec>
<title>Isolation of the Total Bacterial DNA and 16S rDNA Amplicon Sequencing of Microbiota</title>
<p>The extraction of bacterial DNA was performed with the QIAamp Fast Stool DNA Mini Kit (Qiagen) after the mechanical disruption (speed 7,000 for 70 s) with the SeptiFast Lys Kit (Roche) on MagNA Lyser (Roche). The DNA concentration was verified using Quant-iT PicoGreen dsDNA Kit (Thermo Fisher Scientific). Bacterial community composition was determined by paired-end sequencing on an Illumina MiSeq platform, targeting the V3–V4 hypervariable region of the 16S rRNA gene. Library preparation was carried out using the 341F (5′-CCTACGGGNGGCWGCAG-3′) – 805R (5′-GACTACHVGGGTATCTAATCC-3′) set of primers. On the same run a template-free sample was included as a negative sequencing control.</p>
<p>Sequencing data was deposited at metagenomic analysis server MG-RAST (<xref ref-type="bibr" rid="B26">Meyer et al., 2008</xref>) and is accessible at <ext-link ext-link-type="uri" xlink:href="https://www.mg-rast.org/linkin.cgi?project=mgp85501">https://www.mg-rast.org/linkin.cgi?project=mgp85501</ext-link>.</p>
</sec>
<sec>
<title>Analysis of Sequence Data</title>
<p>MiSeq output data was analyzed with statistical tools included in the mothur software (v.1.36.1) (<xref ref-type="bibr" rid="B36">Schloss et al., 2009</xref>), according to the MiSeq standard operating procedure (SOP) for Illumina paired end reads (<xref ref-type="bibr" rid="B17">Kozich et al., 2013</xref>). Sequences with any ambiguous base or more than eight homopolymers were removed from downstream analysis. The remaining sequences were aligned against the Silva reference alignment (<xref ref-type="bibr" rid="B31">Quast et al., 2013</xref>). Chimeras were searched with the UCHIME algorithm (<xref ref-type="bibr" rid="B9">Edgar et al., 2011</xref>) and removed. Classification of sequences was performed using the RDP training set (v.9) with an 80% confidence threshold. Sequences restricted to bacterial origin only were clustered into operational taxonomic units (OTUs) at a 3% dissimilarity level. To adjust for the influence of the number of OTUs in a sample on diversity and other statistical tests, any OTUs with relative abundance lower than 0.001% were removed from further analyses. Chao1 and Shannon indices were chosen to characterize alpha samples diversity. For beta diversity estimation weighted UniFrac measure was used (<xref ref-type="bibr" rid="B23">Lozupone et al., 2007</xref>). Samples hierarchical clustering was obtained with MEGA software (v.7.0.26) (<xref ref-type="bibr" rid="B18">Kumar et al., 2016</xref>) using Bray–Curtis distances as input. OTUs that differed between treatments were selected with respect to linear discriminant analysis (LDA) effect size (LEfSe) method (<xref ref-type="bibr" rid="B37">Segata et al., 2011</xref>).</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title><italic>C. difficile</italic> Can Grow in the Presence of Dysbiotic and Healthy Fecal Microbiota <italic>in Vitro</italic></title>
<p>Two types of fecal microbiota were tested. As explained previously one pooled sample was collected from healthy individuals while the other originated from samples subjected to <italic>C. difficile</italic> testing and were having negative result. Microbiota in such samples was previously and in this study shown to differ from microbiota in healthy samples (see below). Because the differences include characteristics associated with dysbalanced microbiota such as lower diversity and higher proportion of <italic>Proteobacteria</italic>, we are referring to this sample as to dysbiotic.</p>
<p>Each tested <italic>C. difficile</italic> strain showed specific pattern of growth in the presence of healthy or dysbiotic microbiota. Strains of ribotypes 010 and 027 grew best in the presence of dysbiotic microbiota, while ribotype 014/020 strain growth was similar in both microbiota types (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p><bold>(A)</bold> Total viable cell count with corresponding standard deviation for <italic>C. difficile</italic> ribotypes 010, 014/020, and 027 strains in the inoculum (blue), in the control (gray), in co-culture with healthy fecal microbiota (green) and in co-culture with dysbiotic fecal microbiota (orange). <sup>∗</sup>Statistically significant difference. <bold>(B)</bold> Percentage of <italic>C. difficile</italic> spores detected as ethanol resistant CFUs in proportion to total CFUs for ribotypes 010, 014/020, and 027 strains in the control (gray), in combination with healthy microbiota (green) and in combination with dysbiotic microbiota (orange).</p>
</caption>
<graphic xlink:href="fmicb-09-01633-g001"></graphic>
</fig>
<p>In both microbiota types an increase in <italic>C. difficile</italic> total cell count was observed compared to original inoculum, indicating that all three strains were able to proliferate in the presence of disturbed and undisturbed microbiota. Difference between growth in control (growth medium only) and in combination with microbiota (any type) was significant only for PCR ribotype 027 strain (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>).</p>
</sec>
<sec>
<title><italic>C. difficile</italic> Sporulation Is Better in the Presence of Dysbiotic Fecal Microbiota</title>
<p>The <italic>C. difficile</italic> sporulation frequency in co-cultures with fecal microbiota varied between 1.3 and 25.6% (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). All three strains formed higher percentage of spores in co-culture with dysbiotic microbiota (7.0–25.6%), while in the co-culture with healthy microbiota spore percentage was lower (1.3–8.6%). Statistically significantly higher amount of spores in dysbiotic microbiota was observed only for ribotype 010 and 027 strains (one-way ANOVA: <italic>p</italic> &lt; 0.05). Strains of ribotypes 014/020 and 027 displayed similar pattern of sporulation as for both the percentage of spores was the lowest in combination with healthy microbiota. For ribotype 010 strain the lowest sporulation was observed in control samples without fecal microbiota (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>).</p>
</sec>
<sec>
<title>Bacterial Richness and Diversity of Fecal Microbiota Decrease in the Presence of <italic>C. difficile</italic></title>
<p>Sequencing yielded a total of 1,480,790 sequences of bacterial origin, with an average depth of 50,385 sequences per sample. Sequences were classified into 365 OTUs with relative abundance higher than 0.001%.</p>
<p>Input sample of healthy microbiota initially contained lower levels of <italic>Proteobacteria</italic> and higher proportions of <italic>Actinobacteria</italic> and <italic>Firmicutes</italic> than input sample of dysbiotic microbiota (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). After 3 days of <italic>in vitro</italic> incubation the control samples of both types of microbiota displayed similar composition at the phylum level (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). Nevertheless, statistical analysis revealed statistically higher bacterial richness and diversity in samples of healthy microbiota than in samples of dysbiotic microbiota (<italic>p</italic> &lt; 0.05; Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Bacterial phylum level assignments of average relative abundances for fecal input samples (before any cultivation), control samples (fecal microbiota only), and samples of fecal microbiota in combination with <italic>C. difficile</italic> ribotypes 010, 027, and 014/020 strains. Chart <bold>(A)</bold> represents samples of healthy fecal microbiota and chart <bold>(B)</bold> represents samples of dysbiotic fecal microbiota.</p>
</caption>
<graphic xlink:href="fmicb-09-01633-g002"></graphic>
</fig>
<p>Also in comparison of control samples and co-cultures microbiota/<italic>C. difficile</italic> no statistically significant differences (<italic>p</italic> &gt; 0.05) were detected at the phylum level (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>), but significant changes were observed in bacterial richness and diversity (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>) and on lower taxonomic levels (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Alpha diversity estimates Chao1 <bold>(A,B)</bold> and Shannon index <bold>(C,D)</bold> with corresponding standard deviations for control samples of fecal microbiota and samples of fecal microbiota in combination with <italic>C. difficile</italic> ribotypes 010, 027, and 014/020 strains. Charts <bold>(A,C)</bold> represent samples of healthy fecal microbiota and charts <bold>(B,D)</bold> represent samples of dysbiotic fecal microbiota. <sup>∗</sup>Statistically significant difference.</p>
</caption>
<graphic xlink:href="fmicb-09-01633-g003"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Comparison of significantly increased OTUs in control samples (healthy or dysbiotic microbiota only) and in samples of co-cultures (healthy microbiota/<italic>C. difficile</italic> or dysbiotic microbiota/<italic>C. difficile</italic>).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Microbiota type +<italic>C. difficile</italic> ribotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Increased in co-culture</th>
<th align="left" colspan="1" rowspan="1" valign="top">Increased in control (microbiota only)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Healthy + 010</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcus</italic> (Otu00004)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVb</italic> (Otu00043)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Barnesiella</italic> (Otu00024)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus</italic> (Otu00028)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Anaerostipes</italic> (Otu00029)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Morganella</italic> (Otu00107)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Lachnospiraceae</italic> (Otu00118)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus</italic> (Otu00011)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVa</italic> (Otu00032)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Lachnospiraceae</italic> (Otu00015)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Healthy + 014/020</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcus</italic> (Otu00004)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVb</italic> (Otu00043)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Acidaminococcaceae</italic> (Otu00068)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus</italic> (Otu00011)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Barnesiella</italic> (Otu00024)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus</italic> (Otu00028)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Lachnospiraceae</italic> (Otu00118)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Morganella</italic> (Otu00107)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Butyricicoccus</italic> (Otu00051)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Peptostreptococcus</italic> (Otu00035)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Healthy + 027</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcus</italic> (Otu00004)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVb</italic> (Otu00043)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Barnesiella</italic> (Otu00024)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Morganella</italic> (Otu00107)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVa</italic> (Otu00032)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus</italic> (Otu00028)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides</italic> (Otu00048)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Sutterella</italic> (Otu00014)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Peptostreptococcus</italic> (Otu00035)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dysbiotic + 010</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Sutterella</italic> (Otu00014)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Dorea</italic> (Otu00017)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_sensu_stricto</italic> (Otu00006)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia_Shigella</italic> (Otu00001)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides</italic> (Otu00002)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVa</italic> (Otu00032)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Veillonella</italic> (Otu00003)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Lachnospiraceae</italic> (Otu00015)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus</italic> (Otu00012)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Oscillibacter</italic> (Otu00081)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dysbiotic + 014/020</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides</italic> (Otu00002)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Oscillibacter</italic> (Otu00081)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Sutterella</italic> (Otu00014)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVa</italic> (Otu00032)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Veillonella</italic> (Otu00003)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Ruminococcaceae</italic> (Otu00030)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides</italic> (Otu00007)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Eubacteriaceae</italic> (Otu00094)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Parabacteroides</italic> (Otu00021)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Flavonifractor</italic> (Otu00026)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dysbiotic + 027</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Veillonella</italic> (Otu00003)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Dorea</italic> (Otu00017)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Sutterella</italic> (Otu00014)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_XlVa</italic> (Otu00032)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus</italic> (Otu00012)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Oscillibacter</italic> (Otu00081)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium_sensu_stricto</italic> (Otu00006)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Uncl. from <italic>Lachnospiraceae</italic> (Otu00015)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Phascolarctobacterium</italic> (Otu00023)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Flavonifractor</italic> (Otu00026)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Presented OTUs were identified by the LEfSe test (mothur software), which uses linear discriminant analysis (LDA) to find OTUs that significantly differ in abundance between cultures of microbiota only (control) and co-cultures of microbiota and <italic>C. difficile</italic>. For each comparison only top five OTUs with highest LDA scores are presented. For additional information, see Supplementary Tables <xref ref-type="supplementary-material" rid="SM1">S2</xref>, <xref ref-type="supplementary-material" rid="SM1">S3</xref>. Uncl., unclassified.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>To estimate the microbial richness we used the Chao1 index. According to control samples with healthy microbiota alone significantly lower bacterial richness was observed only if healthy microbiota was co-cultured with ribotype 014/020 strain (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>), whereas bacterial richness of dysbiotic microbiota was lowered in the presence of all three strains (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). In addition, significant differences in bacterial richness were observed between co-culture of dysbiotic microbiota with ribotype 027 strain and co-culture of dysbiotic microbiota with ribotype 010 strain (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>).</p>
<p>Shannon index, predicting the microbial diversity, was significantly higher in control samples than in co-cultures microbiota/<italic>C. difficile</italic> (<bold>Figures <xref ref-type="fig" rid="F3">3C,D</xref></bold>). For dysbiotic microbiota that trend was noticeable for all three strains, whereas bacterial diversity of healthy microbiota significantly decreased only in co-culture with ribotype 010 strain.</p>
</sec>
<sec>
<title>Dysbiotic Microbiota Is More Affected by <italic>C. difficile</italic> Than Healthy Microbiota</title>
<p>Bacterial community patterns of control and co-culture samples congregated in two major groups by hierarchical clustering; i.e., samples of dysbiotic microbiota (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>, segment A) and samples of healthy microbiota (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>, segment B). The deepest branching in both groups clearly divided control samples of microbiota only from co-cultures microbiota/<italic>C. difficile</italic> (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>). According to weighted UniFrac test statistically significant differences in OTU composition were observed between control samples (dysbiotic or healthy microbiota only; <bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>, segments a and b) and samples of microbiota (dysbiotic or healthy) in co-culture with all three <italic>C. difficile</italic> ribotypes (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>, segments a1–3 and b1–3).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Hierarchical clustering of samples of dysbiotic fecal microbiota (MNH; segment A) and samples of healthy fecal microbiota (MH; segment B) without and with the addition of <italic>C. difficile</italic> ribotype 010 strain (C100), ribotype 027 strain (E27), and ribotype 014/020 strain (WF260), obtained by MEGA software (v.7.0.26). Statistically significant differences were observed between control samples (dysbiotic or healthy fecal microbiota only; segments a and b) and samples of fecal microbiota (dysbiotic or healthy) with added <italic>C. difficile</italic> ribotypes 010 (segments a2 and b2), 014/020 (segments a1 and b1), and 027 (segments a3 and b3) strains.</p>
</caption>
<graphic xlink:href="fmicb-09-01633-g004"></graphic>
</fig>
<p>To identify significantly changed OTUs we have used the LEfSe test. Altogether, 62 OTUs were affected in co-cultures of dysbiotic microbiota and 45 OTUs in co-cultures of healthy microbiota (Supplementary Tables <xref ref-type="supplementary-material" rid="SM1">S2</xref>, <xref ref-type="supplementary-material" rid="SM1">S3</xref>). The smallest number of OTUs was affected in co-culture of healthy microbiota and <italic>C. difficile</italic> ribotype 027 strain (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>). In general, the majority of significantly changed OTUs in both types of microbiota belonged to the phylum <italic>Firmicutes</italic>, with <italic>Lachnospiraceae</italic> and <italic>Ruminococcaceae</italic> origin. OTUs from both families were mostly associated with control samples of microbiota only (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold> and Supplementary Tables <xref ref-type="supplementary-material" rid="SM1">S2</xref>, <xref ref-type="supplementary-material" rid="SM1">S3</xref>). For <italic>Clostridium_XIVa</italic>, member of <italic>Lachnospiraceae</italic> family, an increase was observed in control samples of dysbiotic microbiota only as well as in co-cultures of healthy microbiota and <italic>C. difficile</italic> (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold> and Supplementary Tables <xref ref-type="supplementary-material" rid="SM1">S2</xref>, <xref ref-type="supplementary-material" rid="SM1">S3</xref>). Members of <italic>Bacteroidetes</italic> (particularly <italic>Bacteroides</italic>), <italic>Firmicutes</italic> (e.g., <italic>Veillonella</italic>) and <italic>Proteobacteria</italic> (i.e., <italic>Sutterella</italic>) were mostly associated with co-cultures of dysbiotic microbiota/<italic>C. difficile</italic>, whereas in co-cultures of healthy microbiota/<italic>C. difficile</italic> taxa from <italic>Bacteroidetes</italic> (i.e., <italic>Barnesiella</italic>) and <italic>Firmicutes</italic> (e.g., <italic>Enterococcus</italic>) were enriched (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>Widespread use of antibiotics in hospitalized as well as in non-hospitalized patients leads to the disturbance of normal gut microbiota and allows <italic>C. difficile</italic> to expand in the gut. However, CDI might occur also in the individuals with no previous exposure to antibiotics or other apparent reason for microbiota disruption (<xref ref-type="bibr" rid="B3">Bauer et al., 2008</xref>; <xref ref-type="bibr" rid="B45">Wilcox et al., 2008</xref>).</p>
<p>To partially address the issue of <italic>C. difficile</italic> proliferation in dysbiotic and non-dysbiotic gut microenvironment, we explored <italic>C. difficile</italic> growth in the presence of two different types of microbiota. As previously <italic>C. difficile</italic> conditioned medium was shown to cause changes in gut microbiota <italic>in vitro</italic> (<xref ref-type="bibr" rid="B15">Horvat et al., 2017</xref>), we have studied if comparable changes are observed also with <italic>C. difficile</italic> vegetative cells.</p>
<p>All tested <italic>C. difficile</italic> strains successfully proliferated in our <italic>in vitro</italic> model with both types of fecal microbiota. That is in contrast to results obtained with some other <italic>in vitro</italic> gut models, where the inability of <italic>C. difficile</italic> to proliferate in the absence of antibiotic disturbance of microbiota was demonstrated (<xref ref-type="bibr" rid="B4">Borriello and Barclay, 1986</xref>; <xref ref-type="bibr" rid="B46">Wilson and Freter, 1986</xref>; <xref ref-type="bibr" rid="B8">Drummond et al., 2003</xref>; <xref ref-type="bibr" rid="B11">Freeman et al., 2003</xref>). Yet, the capability of <italic>C. difficile</italic> to colonize gut microenvironments even in the presence of complex microbial communities was demonstrated for ribotype 027 strains (<xref ref-type="bibr" rid="B33">Robinson et al., 2014</xref>). Therefore, it seems likely that ability of <italic>C. difficile</italic> to compete with complex non-dysbiotic microbial communities is strain dependent.</p>
<p>With the exception of ribotype 014/020 strain, <italic>C. difficile</italic> proliferated to a significantly greater extent in the presence of dysbiotic microbiota than in the presence of healthy microbiota (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>). In addition, greater proportion of OTUs was affected in co-cultures dysbiotic microbiota/<italic>C. difficile</italic> than in co-cultures healthy microbiota/<italic>C. difficile</italic> (Supplementary Tables <xref ref-type="supplementary-material" rid="SM1">S2</xref>, <xref ref-type="supplementary-material" rid="SM1">S3</xref>). Interestingly, the presence of ribotype 027 in healthy microbiota affected only small proportion of OTUs (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>). That is in contrast with several previous studies on symptomatic humans or animals where ribotype 027 correlated with more disturbed microbiota (<xref ref-type="bibr" rid="B19">Lawley et al., 2012</xref>; <xref ref-type="bibr" rid="B32">Rea et al., 2012</xref>; <xref ref-type="bibr" rid="B38">Skraban et al., 2013</xref>).</p>
<p>Considering sporulation, higher proportion of <italic>C. difficile</italic> spores was observed in co-cultures with dysbiotic microbiota. That trend was apparent for all three strains (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). This indicates, that conditions in dysbiotic microbiota support formation of greater amount of spores, which are important for further <italic>C. difficile</italic> transmission and spread. Additionally, an increased spore production appears to be relevant in severe CDI cases (<xref ref-type="bibr" rid="B6">Carlson et al., 2013</xref>).</p>
<p>The explanation of mechanism underlying the observed increased sporulation could be only speculative, as sporulation signals for <italic>C. difficile</italic> are not known (<xref ref-type="bibr" rid="B47">Zhu et al., 2018</xref>) in contrast to well understood germination signals (<xref ref-type="bibr" rid="B42">Theriot and Young, 2014</xref>). Nutrient starvation, quorum sensing and other environmental stimuli are most likely involved in sporulation signaling through several regulatory networks (<xref ref-type="bibr" rid="B47">Zhu et al., 2018</xref>). All of these three potential factors could be also involved in changes of microbiota dependent sporulation frequency.</p>
<p>Presence of <italic>C. difficile</italic> in co-cultures significantly decreased microbial richness and diversity in both types of fecal microbiota, but dysbiotic microbiota seemed to be more responsive and healthy microbiota more robust (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). Diversity was decreased in the presence of all three tested strains. The association of <italic>C. difficile</italic> colonization and/or infection with a decrease in gut microbiota diversity is well documented, but was so far only viewed as a predisposing condition (reviewed in <xref ref-type="bibr" rid="B43">Vincent and Manges, 2015</xref>) and not also as a consequence of <italic>C. difficile</italic> presence as suggested here and elsewhere (<xref ref-type="bibr" rid="B15">Horvat et al., 2017</xref>).</p>
<p>In general, potentially beneficial autochthonous bacteria, particularly butyrate-producing bacteria (<italic>Lachnospiraceae</italic> and <italic>Ruminococcaceae</italic>) were present in larger proportions in microbiota cultivated without <italic>C. difficile</italic>. These bacteria are usually found in healthy subjects and are thought to provide colonization resistance against CDI (<xref ref-type="bibr" rid="B34">Ross et al., 2016</xref>).</p>
<p>The presence of <italic>C. difficile</italic> in any type of microbiota resulted in increased proportions of opportunistic pathogens (i.e., <italic>Sutterella</italic> in co-culture with dysbiotic microbiota and <italic>Enterococcus</italic> in co-culture with healthy microbiota). Previous studies already reported about an increased proportion of <italic>Sutterella</italic> in <italic>C. difficile</italic> positive subjects (<xref ref-type="bibr" rid="B29">Perez-Cobas et al., 2014</xref>; <xref ref-type="bibr" rid="B27">Milani et al., 2016</xref>). Also, the presence of <italic>Sutterella</italic> was linked to several other human diseases, where gut microbiota seems to play a crucial role in their development (e.g., metabolic syndrome and autism) (<xref ref-type="bibr" rid="B44">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="B22">Lim et al., 2017</xref>). An association between <italic>C. difficile</italic> colonization/infection and enterococci or vancomycin-resistant enterococci (VRE) is also well documented (<xref ref-type="bibr" rid="B28">Ozaki et al., 2004</xref>; <xref ref-type="bibr" rid="B7">Choi et al., 2011</xref>; <xref ref-type="bibr" rid="B12">Fujitani et al., 2011</xref>; <xref ref-type="bibr" rid="B40">Stripling et al., 2015</xref>; <xref ref-type="bibr" rid="B25">McKinley et al., 2016</xref>). Moreover, our previous study demonstrated undisturbed growth of representative strain of <italic>Enterococcus</italic> in co-culture with <italic>C. difficile</italic> on agar plates (<xref ref-type="bibr" rid="B15">Horvat et al., 2017</xref>). <italic>Veillonella</italic> was another genus that increased in the presence of <italic>C. difficile</italic> in dysbiotic microbiota. That is in agreement with two other studies (<xref ref-type="bibr" rid="B2">Antharam et al., 2016</xref>; <xref ref-type="bibr" rid="B16">Khanna et al., 2016</xref>) and in contrast to our previous study, where reduced proportions were found in <italic>C. difficile</italic> conditioned medium (<xref ref-type="bibr" rid="B15">Horvat et al., 2017</xref>). Decreased levels of <italic>Veillonella</italic> were also found in oncological patients colonized with <italic>C. difficile</italic> (<xref ref-type="bibr" rid="B48">Zwielehner et al., 2011</xref>).</p>
<p>Our results further support the observation that <italic>C. difficile</italic> could have an impact on gut microbiota and that the impact is strain dependent. Dysbiotic microbiota is <italic>in vitro</italic> more susceptible for disturbances caused by co-culture with <italic>C. difficile</italic> and is also associated with better sporulation frequency of <italic>C. difficile</italic>. Better competitive ability, inhibition of certain bacterial groups associated with colonization resistance and better sporulation in the presence of dysbiotic microbiota possibly contribute to endemic spread of some strains.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>SH performed the experiments and data analysis. MR contributed to the data analysis. Both authors designed the study and contributed to the text preparation and reviewed the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The authors acknowledge the financial support from the Slovenian Research Agency (research core funding P3-0387 and Ph.D. program ‘Mladi raziskovalci’).</p>
</ack>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2018.01633/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2018.01633/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<label></label>
<media xlink:href="Table_1.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguirre</surname><given-names>M.</given-names></name><name><surname>Ramiro-Garcia</surname><given-names>J.</given-names></name><name><surname>Koenen</surname><given-names>M. E.</given-names></name><name><surname>Venema</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>To pool or not to pool? impact of the use of individual and pooled fecal samples for in vitro fermentation studies.</article-title>
<source/><italic>J. Microbiol. Methods</italic>
<volume>107</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.mimet.2014.08.022</pub-id>
<pub-id pub-id-type="pmid">25194233</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antharam</surname><given-names>V.</given-names></name><name><surname>McEwen</surname><given-names>D.</given-names></name><name><surname>Garrett</surname><given-names>T.</given-names></name><name><surname>Dossey</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>E.</given-names></name><name><surname>Kozlov</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>An integrated metabolomic and microbiome analysis identified specific gut microbiota associated with fecal cholesterol and coprostanol in <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0148824</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0148824</pub-id>
<pub-id pub-id-type="pmid">26871580</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>M. P.</given-names></name><name><surname>Goorhuis</surname><given-names>A.</given-names></name><name><surname>Koster</surname><given-names>T.</given-names></name><name><surname>Numan-Ruberg</surname><given-names>S. C.</given-names></name><name><surname>Hagen</surname><given-names>E. C.</given-names></name><name><surname>Debast</surname><given-names>S. B.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Community-onset <italic>Clostridium difficile</italic>-associated diarrhoea not associated with antibiotic usage–two case reports with review of the changing epidemiology of <italic>Clostridium difficile</italic>-associated diarrhoea.</article-title>
<source/><italic>Neth. J. Med.</italic>
<volume>66</volume>
<fpage>207</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="pmid">18490799</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borriello</surname><given-names>S. P.</given-names></name><name><surname>Barclay</surname><given-names>F. E.</given-names></name></person-group> (<year>1986</year>). <article-title>An in-vitro model of colonisation resistance to <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>J. Med. Microbiol.</italic>
<volume>21</volume>
<fpage>299</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1099/00222615-21-4-299</pub-id>
<pub-id pub-id-type="pmid">3723582</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britton</surname><given-names>R. A.</given-names></name><name><surname>Young</surname><given-names>V. B.</given-names></name></person-group> (<year>2012</year>). <article-title>Interaction between the intestinal microbiota and host in <italic>Clostridium difficile</italic> colonization resistance.</article-title>
<source/><italic>Trends Microbiol.</italic>
<volume>20</volume>
<fpage>313</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2012.04.001</pub-id>
<pub-id pub-id-type="pmid">22595318</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>P. E.</given-names></name><name><surname>Walk</surname><given-names>S. T.</given-names></name><name><surname>Bourgis</surname><given-names>A. E.</given-names></name><name><surname>Liu</surname><given-names>M. W.</given-names></name><name><surname>Kopliku</surname><given-names>F.</given-names></name><name><surname>Lo</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The relationship between phenotype, ribotype, and clinical disease in human <italic>Clostridium difficile</italic> isolates.</article-title>
<source/><italic>Anaerobe</italic>
<volume>24</volume>
<fpage>109</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2013.04.003</pub-id>
<pub-id pub-id-type="pmid">23608205</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Risk factors for recurrence of <italic>Clostridium difficile</italic> infection: effect of vancomycin-resistant <italic>Enterococci</italic> colonization.</article-title>
<source/><italic>J. Korean Med. Sci.</italic>
<volume>26</volume>
<fpage>859</fpage>–<lpage>864</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2011.26.7.859</pub-id>
<pub-id pub-id-type="pmid">21738336</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>L. J.</given-names></name><name><surname>Smith</surname><given-names>D. G.</given-names></name><name><surname>Poxton</surname><given-names>I. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by <italic>Clostridium difficile</italic>.</article-title>
<source/><italic>J. Med. Microbiol.</italic>
<volume>52</volume>(Pt 12), <fpage>1033</fpage>–<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.05387-0</pub-id>
<pub-id pub-id-type="pmid">14614060</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>R. C.</given-names></name><name><surname>Haas</surname><given-names>B. J.</given-names></name><name><surname>Clemente</surname><given-names>J. C.</given-names></name><name><surname>Quince</surname><given-names>C.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>UCHIME improves sensitivity and speed of chimera detection.</article-title>
<source/><italic>Bioinformatics</italic>
<volume>27</volume>
<fpage>2194</fpage>–<lpage>2200</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr381</pub-id>
<pub-id pub-id-type="pmid">21700674</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreyra</surname><given-names>J. A.</given-names></name><name><surname>Ng</surname><given-names>K. M.</given-names></name><name><surname>Sonnenburg</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>The enteric two-step: nutritional strategies of bacterial pathogens within the gut.</article-title>
<source/><italic>Cell. Microbiol.</italic>
<volume>16</volume>
<fpage>993</fpage>–<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1111/cmi.12300</pub-id>
<pub-id pub-id-type="pmid">24720567</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>J.</given-names></name><name><surname>O’Neill</surname><given-names>F. J.</given-names></name><name><surname>Wilcox</surname><given-names>M. H.</given-names></name></person-group> (<year>2003</year>). <article-title>Effects of cefotaxime and desacetylcefotaxime upon <italic>Clostridium difficile</italic> proliferation and toxin production in a triple-stage chemostat model of the human gut.</article-title>
<source/><italic>J. Antimicrob. Chemother.</italic>
<volume>52</volume>
<fpage>96</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkg267</pub-id>
<pub-id pub-id-type="pmid">12775682</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujitani</surname><given-names>S.</given-names></name><name><surname>George</surname><given-names>W.</given-names></name><name><surname>Morgan</surname><given-names>M.</given-names></name><name><surname>Nichols</surname><given-names>S.</given-names></name><name><surname>Murthy</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Implications for vancomycin-resistant <italic>Enterococcus</italic> colonization associated with <italic>Clostridium difficile</italic> infections.</article-title>
<source/><italic>Am. J. Infect. Control</italic>
<volume>39</volume>
<fpage>188</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajic.2010.10.024</pub-id>
<pub-id pub-id-type="pmid">21458682</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerding</surname><given-names>D. N.</given-names></name><name><surname>Johnson</surname><given-names>S.</given-names></name><name><surname>Rupnik</surname><given-names>M.</given-names></name><name><surname>Aktories</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Clostridium difficile</italic> binary toxin CDT: mechanism, epidemiology, and potential clinical importance.</article-title>
<source/><italic>Gut Microbes</italic>
<volume>5</volume>
<fpage>15</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.26854</pub-id>
<pub-id pub-id-type="pmid">24253566</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Khanna</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Community-acquired <italic>Clostridium difficile</italic> infection: an increasing public health threat.</article-title>
<source/><italic>Infect. Drug Resist.</italic>
<volume>7</volume>
<fpage>63</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.2147/IDR.S46780</pub-id>
<pub-id pub-id-type="pmid">24669194</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvat</surname><given-names>S.</given-names></name><name><surname>Mahnic</surname><given-names>A.</given-names></name><name><surname>Breskvar</surname><given-names>M.</given-names></name><name><surname>Dzeroski</surname><given-names>S.</given-names></name><name><surname>Rupnik</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Evaluating the effect of <italic>Clostridium difficile</italic> conditioned medium on fecal microbiota community structure.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>16448</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-154341</pub-id>
<pub-id pub-id-type="pmid">29180685</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>S.</given-names></name><name><surname>Montassier</surname><given-names>E.</given-names></name><name><surname>Schmidt</surname><given-names>B.</given-names></name><name><surname>Patel</surname><given-names>R.</given-names></name><name><surname>Knights</surname><given-names>D.</given-names></name><name><surname>Pardi</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Gut microbiome predictors of treatment response and recurrence in primary <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>Aliment. Pharmacol. Ther.</italic>
<volume>44</volume>
<fpage>715</fpage>–<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1111/apt.13750</pub-id>
<pub-id pub-id-type="pmid">27481036</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozich</surname><given-names>J.</given-names></name><name><surname>Westcott</surname><given-names>S.</given-names></name><name><surname>Baxter</surname><given-names>N.</given-names></name><name><surname>Highlander</surname><given-names>S.</given-names></name><name><surname>Schloss</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the miseq illumina sequencing platform.</article-title>
<source/><italic>Appl. Environ. Microbiol.</italic>
<volume>79</volume>
<fpage>5112</fpage>–<lpage>5120</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01043-13</pub-id>
<pub-id pub-id-type="pmid">23793624</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Stecher</surname><given-names>G.</given-names></name><name><surname>Tamura</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>MEGA7: molecular evolutionary genetics analysis version 7.0 for Bigger Datasets.</article-title>
<source/><italic>Mol. Biol. Evol.</italic>
<volume>33</volume>
<fpage>1870</fpage>–<lpage>1874</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msw054</pub-id>
<pub-id pub-id-type="pmid">27004904</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawley</surname><given-names>T. D.</given-names></name><name><surname>Clare</surname><given-names>S.</given-names></name><name><surname>Walker</surname><given-names>A. W.</given-names></name><name><surname>Stares</surname><given-names>M. D.</given-names></name><name><surname>Connor</surname><given-names>T. R.</given-names></name><name><surname>Raisen</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing <italic>Clostridium difficile</italic> disease in mice.</article-title>
<source/><italic>PLoS Pathog.</italic>
<volume>8</volume>:<issue>e1002995</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002995</pub-id>
<pub-id pub-id-type="pmid">23133377</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>P.</given-names></name><name><surname>Citron</surname><given-names>D.</given-names></name><name><surname>Tyrrell</surname><given-names>K.</given-names></name><name><surname>Finegold</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Reclassification of <italic>Clostridium difficile</italic> as <italic>Clostridioides difficile</italic> (Hall and O’Toole 1935) prevot 1938.</article-title>
<source/><italic>Anaerobe</italic>
<volume>40</volume>
<fpage>95</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2016.06.008</pub-id>
<pub-id pub-id-type="pmid">27370902</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leffler</surname><given-names>D.</given-names></name><name><surname>Lamont</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>New Eng. J. Med.</italic>
<volume>372</volume>
<fpage>1539</fpage>–<lpage>1548</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1403772</pub-id>
<pub-id pub-id-type="pmid">25875259</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>M. Y.</given-names></name><name><surname>You</surname><given-names>H. J.</given-names></name><name><surname>Yoon</surname><given-names>H. S.</given-names></name><name><surname>Kwon</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>J. Y.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The effect of heritability and host genetics on the gut microbiota and metabolic syndrome.</article-title>
<source/><italic>Gut</italic>
<volume>66</volume>
<fpage>1031</fpage>–<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2015-311326</pub-id>
<pub-id pub-id-type="pmid">27053630</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozupone</surname><given-names>C. A.</given-names></name><name><surname>Hamady</surname><given-names>M.</given-names></name><name><surname>Kelley</surname><given-names>S. T.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities.</article-title>
<source/><italic>Appl. Environ. Microbiol.</italic>
<volume>73</volume>
<fpage>1576</fpage>–<lpage>1585</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01996-06</pub-id>
<pub-id pub-id-type="pmid">17220268</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Monaghan</surname><given-names>T.</given-names></name><name><surname>Wilcox</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Clostridium difficile</italic> infection: epidemiology, diagnosis and understanding transmission.</article-title>
<source/><italic>Nat. Rev. Gastroenterol. Hepatol.</italic>
<volume>13</volume>
<fpage>206</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2016.25</pub-id>
<pub-id pub-id-type="pmid">26956066</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinley</surname><given-names>L.</given-names></name><name><surname>Becerra</surname><given-names>B.</given-names></name><name><surname>Moriarty</surname><given-names>H.</given-names></name><name><surname>Short</surname><given-names>T. H.</given-names></name><name><surname>Hagle</surname><given-names>M.</given-names></name><name><surname>Reymann</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Vancomycin-resistant <italic>Enterococcus</italic> co-colonization rates with methicillin-resistant <italic>Staphylococcus aureus</italic> and <italic>Clostridium difficile</italic> in critically ill veterans.</article-title>
<source/><italic>Am. J. Infect. Control</italic>
<volume>44</volume>
<fpage>1047</fpage>–<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajic.2016.02.005</pub-id>
<pub-id pub-id-type="pmid">27067517</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>F.</given-names></name><name><surname>Paarmann</surname><given-names>D.</given-names></name><name><surname>D’Souza</surname><given-names>M.</given-names></name><name><surname>Olson</surname><given-names>R.</given-names></name><name><surname>Glass</surname><given-names>E. M.</given-names></name><name><surname>Kubal</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomes.</article-title>
<source/><italic>BMC Bioinformatics</italic>
<volume>19</volume>:<issue>386</issue>. <pub-id pub-id-type="doi">10.1186/1471-2105-9-386</pub-id>
<pub-id pub-id-type="pmid">18803844</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milani</surname><given-names>C.</given-names></name><name><surname>Ticinesi</surname><given-names>A.</given-names></name><name><surname>Gerritsen</surname><given-names>J.</given-names></name><name><surname>Nouvenne</surname><given-names>A.</given-names></name><name><surname>Lugli</surname><given-names>G.</given-names></name><name><surname>Mancabelli</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Gut microbiota composition and <italic>Clostridium difficile</italic> infection in hospitalized elderly individuals: a metagenomic study.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>25945</issue>. <pub-id pub-id-type="doi">10.1038/srep25945</pub-id>
<pub-id pub-id-type="pmid">27166072</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>E.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Kita</surname><given-names>H.</given-names></name><name><surname>Karasawa</surname><given-names>T.</given-names></name><name><surname>Maegawa</surname><given-names>T.</given-names></name><name><surname>Koino</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title><italic>Clostridium difficile</italic> colonization in healthy adults: transient colonization and correlation with <italic>Enterococcal</italic> colonization.</article-title>
<source/><italic>J. Med. Microbiol.</italic>
<volume>53</volume>
<fpage>167</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.05376-0</pub-id>
<pub-id pub-id-type="pmid">14729940</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Cobas</surname><given-names>A.</given-names></name><name><surname>Artacho</surname><given-names>A.</given-names></name><name><surname>Ott</surname><given-names>S.</given-names></name><name><surname>Moya</surname><given-names>A.</given-names></name><name><surname>Gosalbes</surname><given-names>M.</given-names></name><name><surname>Latorre</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Structural and functional changes in the gut microbiota associated to <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>Front. Microbiol.</italic>
<volume>5</volume>:<issue>335</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2014.00335</pub-id>
<pub-id pub-id-type="pmid">25309515</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Cobas</surname><given-names>A.</given-names></name><name><surname>Moya</surname><given-names>A.</given-names></name><name><surname>Gosalbes</surname><given-names>M.</given-names></name><name><surname>Latorre</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Colonization resistance of the gut microbiota against <italic>Clostridium difficile</italic>.</article-title>
<source/><italic>Antibiotics</italic>
<volume>4</volume>
<fpage>337</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics4030337</pub-id>
<pub-id pub-id-type="pmid">27025628</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quast</surname><given-names>C.</given-names></name><name><surname>Pruesse</surname><given-names>E.</given-names></name><name><surname>Yilmaz</surname><given-names>P.</given-names></name><name><surname>Gerken</surname><given-names>J.</given-names></name><name><surname>Schweer</surname><given-names>T.</given-names></name><name><surname>Yarza</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The SILVA ribosomal RNA gene database project: improved data processing and web-based tools.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>41</volume>
<fpage>D590</fpage>–<lpage>D596</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1219</pub-id>
<pub-id pub-id-type="pmid">23193283</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>M. C.</given-names></name><name><surname>O’Sullivan</surname><given-names>O.</given-names></name><name><surname>Shanahan</surname><given-names>F.</given-names></name><name><surname>O’Toole</surname><given-names>P. W.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title><italic>Clostridium difficile</italic> carriage in elderly subjects and associated changes in the intestinal microbiota.</article-title>
<source/><italic>J. Clin. Microbiol.</italic>
<volume>50</volume>
<fpage>867</fpage>–<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.05176-11</pub-id>
<pub-id pub-id-type="pmid">22162545</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>C.</given-names></name><name><surname>Auchtung</surname><given-names>J.</given-names></name><name><surname>Collins</surname><given-names>J.</given-names></name><name><surname>Britton</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Epidemic <italic>Clostridium difficile</italic> strains demonstrate increased competitive fitness compared to nonepidemic isolates.</article-title>
<source/><italic>Infect. Immun.</italic>
<volume>82</volume>
<fpage>2815</fpage>–<lpage>2825</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01524-14</pub-id>
<pub-id pub-id-type="pmid">24733099</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>C. L.</given-names></name><name><surname>Spinler</surname><given-names>J. K.</given-names></name><name><surname>Savidge</surname><given-names>T. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Structural and functional changes within the gut microbiota and susceptibility to <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>Anaerobe</italic>
<volume>41</volume>
<fpage>37</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2016.05.006</pub-id>
<pub-id pub-id-type="pmid">27180006</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rupnik</surname><given-names>M.</given-names></name><name><surname>Wilcox</surname><given-names>M.</given-names></name><name><surname>Gerding</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title><italic>Clostridium difficile</italic> infection: new developments in epidemiology and pathogenesis.</article-title>
<source/><italic>Nat. Rev. Microbiol.</italic>
<volume>7</volume>
<fpage>526</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2164</pub-id>
<pub-id pub-id-type="pmid">19528959</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schloss</surname><given-names>P.</given-names></name><name><surname>Westcott</surname><given-names>S.</given-names></name><name><surname>Ryabin</surname><given-names>T.</given-names></name><name><surname>Hall</surname><given-names>J.</given-names></name><name><surname>Hartmann</surname><given-names>M.</given-names></name><name><surname>Hollister</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.</article-title>
<source/><italic>Appl. Environ. Microbiol.</italic>
<volume>75</volume>
<fpage>7537</fpage>–<lpage>7541</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01541-09</pub-id>
<pub-id pub-id-type="pmid">19801464</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segata</surname><given-names>N.</given-names></name><name><surname>Izard</surname><given-names>J.</given-names></name><name><surname>Waldron</surname><given-names>L.</given-names></name><name><surname>Gevers</surname><given-names>D.</given-names></name><name><surname>Miropolsky</surname><given-names>L.</given-names></name><name><surname>Garrett</surname><given-names>W. S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Metagenomic biomarker discovery and explanation.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>12</volume>:<issue>R60</issue>. <pub-id pub-id-type="doi">10.1186/gb-2011-12-6-r60</pub-id>
<pub-id pub-id-type="pmid">21702898</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skraban</surname><given-names>J.</given-names></name><name><surname>Dzeroski</surname><given-names>S.</given-names></name><name><surname>Zenko</surname><given-names>B.</given-names></name><name><surname>Mongus</surname><given-names>D.</given-names></name><name><surname>Gangl</surname><given-names>S.</given-names></name><name><surname>Rupnik</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Gut microbiota patterns associated with colonization of different <italic>Clostridium difficile</italic> ribotypes.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e58005</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0058005</pub-id>
<pub-id pub-id-type="pmid">23469128</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stecher</surname><given-names>B.</given-names></name><name><surname>Robbiani</surname><given-names>R.</given-names></name><name><surname>Walker</surname><given-names>A. W.</given-names></name><name><surname>Westendorf</surname><given-names>A. M.</given-names></name><name><surname>Barthel</surname><given-names>M.</given-names></name><name><surname>Kremer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>5</volume>:<issue>e244</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0050244</pub-id>
<pub-id pub-id-type="pmid">17760501</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stripling</surname><given-names>J.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Baddley</surname><given-names>J.</given-names></name><name><surname>Nellore</surname><given-names>A.</given-names></name><name><surname>Dixon</surname><given-names>P.</given-names></name><name><surname>Howard</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Loss of vancomycin-resistant <italic>Enterococcus</italic> fecal dominance in an organ transplant patient with <italic>Clostridium difficile</italic> colitis after fecal microbiota transplant.</article-title>
<source/><italic>Open Forum Infect. Dis.</italic>
<volume>2</volume>:<issue>ofv078</issue>. <pub-id pub-id-type="doi">10.1093/ofid/ofv078</pub-id>
<pub-id pub-id-type="pmid">26180828</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studer</surname><given-names>N.</given-names></name><name><surname>Desharnais</surname><given-names>L.</given-names></name><name><surname>Beutler</surname><given-names>M.</given-names></name><name><surname>Brugiroux</surname><given-names>S.</given-names></name><name><surname>Terrazos</surname><given-names>M. A.</given-names></name><name><surname>Menin</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Functional intestinal bile acid 7α-Dehydroxylation by <italic>Clostridium scindens</italic> associated with protection from <italic>Clostridium difficile</italic> infection in a gnotobiotic mouse model.</article-title>
<source/><italic>Front. Cell. Infect. Microbiol.</italic>
<volume>6</volume>:<issue>191</issue>
<pub-id pub-id-type="doi">10.3389/fcimb.2016.00191</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theriot</surname><given-names>C. M.</given-names></name><name><surname>Young</surname><given-names>V. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbial and metabolic interactions between the gastrointestinal tract and <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>Gut Microbes</italic>
<volume>5</volume>
<fpage>86</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.27131</pub-id>
<pub-id pub-id-type="pmid">24335555</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>C.</given-names></name><name><surname>Manges</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Antimicrobial use, human gut microbiota and <italic>Clostridium difficile</italic> colonization and infection.</article-title>
<source/><italic>Antibiotics</italic>
<volume>4</volume>
<fpage>230</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics4030230</pub-id>
<pub-id pub-id-type="pmid">27025623</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Christophersen</surname><given-names>C. T.</given-names></name><name><surname>Sorich</surname><given-names>M. J.</given-names></name><name><surname>Gerber</surname><given-names>J. P.</given-names></name><name><surname>Angley</surname><given-names>M. T.</given-names></name><name><surname>Conlon</surname><given-names>M. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Increased abundance of <italic>Sutterella</italic> spp. and <italic>Ruminococcus torques</italic> in feces of children with autism spectrum disorder.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>4</volume>:<issue>42</issue>. <pub-id pub-id-type="doi">10.1186/2040-2392-4-42</pub-id>
<pub-id pub-id-type="pmid">24188502</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>M. H.</given-names></name><name><surname>Mooney</surname><given-names>L.</given-names></name><name><surname>Bendall</surname><given-names>R.</given-names></name><name><surname>Settle</surname><given-names>C. D.</given-names></name><name><surname>Fawley</surname><given-names>W. N.</given-names></name></person-group> (<year>2008</year>). <article-title>A case-control study of community-associated <italic>Clostridium difficile</italic> infection.</article-title>
<source/><italic>J. Antimicrob. Chemother.</italic>
<volume>62</volume>
<fpage>388</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkn163</pub-id>
<pub-id pub-id-type="pmid">18434341</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>K. H.</given-names></name><name><surname>Freter</surname><given-names>R.</given-names></name></person-group> (<year>1986</year>). <article-title>Interaction of <italic>Clostridium difficile</italic> and <italic>Escherichia coli</italic> with microfloras in continuous-flow cultures and gnotobiotic mice.</article-title>
<source/><italic>Infect. Immun.</italic>
<volume>54</volume>
<fpage>354</fpage>–<lpage>358</lpage>
<pub-id pub-id-type="pmid">3533778</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>D.</given-names></name><name><surname>Sorg</surname><given-names>J. A.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>Clostridioides difficile</italic> biology: sporulation, germination, and corresponding therapies for C. <italic>difficile</italic> Infection.</article-title>
<source/><italic>Front. Cell. Infect. Microbiol.</italic>
<volume>8</volume>:<issue>29</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00029</pub-id>
<pub-id pub-id-type="pmid">29473021</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwielehner</surname><given-names>J.</given-names></name><name><surname>Lassl</surname><given-names>C.</given-names></name><name><surname>Hippe</surname><given-names>B.</given-names></name><name><surname>Pointner</surname><given-names>A.</given-names></name><name><surname>Switzeny</surname><given-names>O.</given-names></name><name><surname>Remely</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e28654</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028654</pub-id>
<pub-id pub-id-type="pmid">22194876</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>